Fibrodysplasia ossificans progressiva: Why do some people have two skeletons?

Journal of Clinical Rheumatology

Volumn 3, Issue 2 SUPPL., 1997, Pages

  Shore, Eileen M ^a   Gannon, Francis H ^a   Kaplan, Frederick S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone morphogenetic proteins; Fibrodysplasia ossificans progressiva; Heterotopic ossification

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

BONE DEVELOPMENT; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DISEASE SEVERITY; GENETIC DISORDER; HETEROTOPIC OSSIFICATION; HUMAN; OSSIFYING MYOSITIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030947536     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199704001-00019     Document Type: Conference Paper

References (30)

1. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 1982;64:76-83.
2. Cohen RB, Hahn GV, Tabas JA, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 1993;75:215-9.
3. Connor JM, Skirton H, Lunt PW. A three generation family with fibrodysplasia ossificans progressiva. J Med Genet 1993;30:687-9.
4. Kaplan FS, McCluskey W, Hahn G, Tabas JA, Muenke M, Zasloff MA. Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family. J Bone Joint Surg Am 1993;75:1214-20.
5. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop 1994;301:243-8.
6. Kaplan FS, Tabas JA, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am 1993;75:220-30.
7. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS. Permanent heterotopic ossification at the injection site after diphtheriatetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 1995;126:762-4.
8. Shah PB, Zasloff MA, Drummond D, Kaplan FS. Spinal deformity in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 1994;76:1442-50.
9. Kaplan FS, Tabas JA, Zasloff MA. Fibrodysplasia ossificans progressiva: a clue from the fly? Calcif Tissue Int 1990;47:117-25.
10. Janoff HB, Tabas JA, Shore EM, et al. Mild expression of fibrodysplasia ossificans progressiva: a report of 3 cases. J Rheumatol 1995;22:976-8.
11. Kaplan FS, Strear CM, Zasloff MA. Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva. Clin Orthop 1994:238-47.
12. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
13. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
14. Urist MR. Bone formation by autoinduction. Science 1965;150:893-9.
15. Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 1992;71:399-410.
16. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 1994;368:639-43.
17. Jones CM, Lyons KM, Hogan BL. Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991;111:531-42.
18. Francis PH, Richardson MK, Brickell PM, Tickle C. Bone morphogenetic proteins and a signalling pathway that controls patterning in the developing chick limb. Development 1994;120:209-18.
19. Vainio S, Karavanova I, Jowett A, Thesleff I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993;75:45-58.
20. Padgett RW, Wozney JM, Gelbart WM. Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo. Proc Natl Acad Sci USA 1993;90:2905-9.
21. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995;15:141-51.
22. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105-16.
23. Francis-West PH, Richardson MK, Bell E, et al. The effect of overexpression of BMP-4 and GDF-5 on the development of limb skeletal elements. Trans Orthop Research Soc 1996;21:62-11.
24. Sampath TK, Rashka KE, Doctor JS, Tucker RF, Hoffmann FM. Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals. Proc Natl Acad Sci USA 1993;90:6004-8.
25. Gannon FH, Kaplan FS, Olmsted E, Finkel GC, Zasloff M, Shore E. Bone morphogenetic protein (BMP) 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. Hum Pathol. In press.
26. Shafritz AB, Shore EM, Gannon FH, et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996;335:555-61.
27. Reddi AH, Cunningham NS. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 1993;8 Suppl 2:S499-502.
28. Nakase T, Nomura S, Yoshikawa H, et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994;9:651-9.
29. Bostrom MP, Lane JM, Berberian WS, et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995;13:357-67.
30. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995;10:1272-81.